GlassScriptPhysician profile
Ashley Parbo
NPI 1881329373
$2,388.66
in general payments reported to CMS, 2019-2025
14 companies · $1,014 in 2025
The $1,014 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $424 · 2024: $950 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,388.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $785.28 | 2023-2025 | Vemlidy, Epclusa |
| Phathom Pharmaceuticals, INC. | $429.24 | 2024-2025 | Voquezna |
| Abbvie INC. | $273.62 | 2023-2025 | |
| Madrigal Pharmaceuticals | $233.60 | 2024-2025 | Rezdiffra, Resmetirom |
| Pfizer INC. | $165.20 | 2024 | |
| Lucid Diagnostics INC. | $127.34 | 2023 | |
| Novo Nordisk INC | $121.44 | 2023 | Wegovy |
| Exact Sciences Corporation | $119.77 | 2025 | The Cologuard Plus Collection Kit |
| Ipsen Biopharmaceuticals, INC | $28.11 | 2025 | Iqirvo |
| Echosens North America, INC. | $24.78 | 2025 | Fibroscan |
| Janssen Biotech, INC. | $23.26 | 2023 | Simponi Aria, Remicade, Simponi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.95 | 2024 | Xifaxan |
| Ardelyx, INC. | $18.69 | 2023 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $15.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Parbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.